Reductions in biomarkers of Alzheimer’s disease pathophysiology following treatment with aducanumab were associated with slowing in clinical decline

Authors :: Raj Rajagovindan
Tianle Chen
Laura Nisenbaum
Ying Tian
Kumar Kandadi Muralidharan
Gersham Dent
Ping He
Carmen Castrillo‐Viguera
Samantha Budd Haeberlein
Source :: Alzheimer's & Dementia. 17
Publication Year :: 2021
Publisher :: Wiley, 2021.

Subjects :: Psychiatry and Mental health
Cellular and Molecular Neuroscience
Developmental Neuroscience
Epidemiology
Health Policy
Neurology (clinical)
Geriatrics and Gerontology

Tools